Page 7 - Astrazeneca

Study finds slightly increased blood clot rates after AstraZeneca Covid jab

A large study in Denmark, Norway has found slightly increased rates of vein blood clots, including in the brain, among adults who had received their first dose of the Oxford-AstraZeneca Covid vaccine

US President Biden hopes to send AstraZeneca vaccine to countries by July 4

President Joe Biden provided an update on White House on goals for providing AstraZeneca Covid-19 vaccines to countries by July 4

US lawmakers seek briefing on plans to export vaccines to other countries

A group of American lawmakers has sought from the Biden Administration a briefing on how they plan to provide Covid-19 vaccines to India and other countries experiencing a surge in coronavirus cases

AstraZeneca reports Covid vaccine sales of $275 mn, expects hit to ease

The results come after a bruising start to the year as the drugmaker struggles with production of its vaccine and faces a legal battle after cutting deliveries to Europe

AstraZeneca first-quarter Covid-19 vaccine revenue at $275 million

This is the first time the drugmaker has given financial details from the distribution and sales of its vaccine.

US won't release AstraZeneca's vaccine until sure about safety: Official

The US FDA will not release AstraZeneca's coronavirus vaccine for export to other countries until it is sure the doses have been manufactured to US quality standards and will be safe and effective

Rich countries' vaccine nationalism to backfire as Covid worsens in India

Variants emerging in India pose worldwide threat, experts say; India's vaccine shortages in part blamed on US export curbs

India expects biggest share of US doses of AstraZeneca vaccine: Report

On Monday, the White House said 10 mn of the 60 mn doses could be cleared for export 'in coming weeks' and the rest by June

US says it will share 60 million AstraZeneca vaccine doses with world

The inoculation is used around the world but has not yet been authorised by the US Food and Drug Administration.

EU sues AstraZeneca over breach of coronavirus vaccine supply contract

AstraZeneca said in response that the legal action by the EU was without merit and pledged to defend itself strongly in court

EU launches legal action against AstraZeneca over vaccine contract

AstraZeneca allegedly failed to respect the terms of its contract with the EU

Pressure on Biden admin to ship AstraZeneca vaccine, supplies to India

Congresswoman Rashida Talib tweeted that the Covid-19 crisis in India is a harsh reminder that the pandemic is not over until the whole world is safe

Even a single vaccine dose cuts Covid-19 infection rate, new UK study finds

A single dose of either the Oxford/AstraZeneca or Pfizer/BioNTech vaccines, currently being administered in the UK, cut the rate of coronavirus infections by around 65%

Astrazeneca is yellow, Pfizer green: Hungary's Covid vaccine-themed treats

At a patisserie in the small town of Vere­segyhaz, the choice is between a selection of layered mousses with colourful jelly toppings, presented in small glasses, with decorative syringes on top

Govt fast-tracks Covid-19 fight, to start vaccination for 18+ from May 1

States allowed to procure directly from manufacturers; open market supply permitted

AstraZeneca could have Covid-19 vaccine against variant by 2021 end

Walters blamed challenges - including delivery delays for the AstraZeneca shot in the European Union - on the "complex process" of producing a vaccine

From Sputnik V to Moderna, here's a snapshot of Covid-19 vaccines

Of this list, Sputnik V is already approved in India and Sinovac is unlikely to come in as it does not meet the aforementioned criteria

Govt push to step up Covid-19 vaccine output 10 times by September

Bharat Biotech and 3 PSEs to ramp up Covaxin production capacity

Europe has surpassed 1 million deaths from Covid-19 pandemic, says WHO

Dr Hans Kluge also said the risk of people suffering blood clots is far higher for people with Covid-19 than people who receive AstraZeneca's coronavirus vaccine.

US weighs next steps for J&J virus shot amid clot mystery

U.S. health officials are weighing next steps as they investigate a handful of unusual blood clots in people who received Johnson&Johnson's COVID-19 vaccine a one-dose shot that many countries were eagerly awaiting to help speed virus protection. It's not clear if the exceedingly rare reports so far, six cases out of more than 7 million inoculations in the U.S. really are linked to the J&J vaccine. But the government recommended a pause in J&J vaccinations on Tuesday, just a week after European regulators declared that such clots are a rare but possible risk with the AstraZeneca vaccine, a shot made in a similar way but not yet approved for use in the U.S. The clots occurred in strange places, in veins that drain blood from the brain, and in people with abnormally low levels of clot-forming platelets. The six cases raised an alarm bell because that number is at least three times more than experts would have expected to see even of more typical brain-drainage clots, said